Morvus Technology Limited is a privately owned pharmaceutical company specialising in the discovery and development of novel drugs and diagnostics for the oncology sector. It has offices near Brecon, Wales. Morvus was formed in 2004 after the founders’ previous company, Enact Pharma plc, was acquired. Initially based on the Porton Down Science Park, near Salisbury, in 2007 the company relocated, with considerable assistance from the Welsh Government, to its present site. The company has a diverse portfolio of oncology therapeutics and diagnostics and its lead drug is a potent anti-tumour agent that displays minimal toxicity to normal tissues and is rendered harmless in the circulation. Morvus is developing this drug as a potential treatment for lung cancer using an inhalation route to deliver the drug to tumour sites. The drug is also being assessed as a potential agent to treat some skin cancers.
View Top Employees from Morvus Technology LtdWebsite | http://www.morvus.com |
Revenue | $6 million |
Employees | 5 (2 on RocketReach) |
Founded | 2004 |
Address | LLANVETHERINE Ct, Llanvetherine, Monmouthshire NP7 8NL, GB |
Phone | +44 1873 821333 |
Technologies |
JavaScript,
HTML,
PHP
+12 more
(view full list)
|
Industry | Biotechnology, Pharmaceutical Manufacturing, Pharmaceuticals, Science and Engineering, Healthcare, Genetics, Health Care |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Morvus Technology Ltd employee's phone or email?
The Morvus Technology Ltd annual revenue was $6 million in 2024.
Richard Knox is the R7D Director of Morvus Technology Ltd.
2 people are employed at Morvus Technology Ltd.
Morvus Technology Ltd is based in Llanvetherine, Monmouthshire.
The NAICS codes for Morvus Technology Ltd are [32541, 325, 3254, 32].
The SIC codes for Morvus Technology Ltd are [283, 28].